They suggest that patients with hypertension, diabetes, and cardiovascular diseases should reduce the use of ACE inhibitors and Ang II-AT1 blockers because these medicines can increase the expression of ACE2 [51]. The gene discussed is ACE2; the disease is Hypertension.